• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Office of Drug Evaluation II (ODE II)

 

Our Mission - The Office of Drug Evaluation II is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for addiction, allergy, analgesia, anesthesia, diabetes, endocrine, metabolism, pulmonary, and rheumatological conditions. 
 
Immediate Office:
 
Director: Curtis J. Rosebraugh, M.D., M.P.H. 
Deputy Director: Mary H. Parks, M.D.
Associate Director for Regulatory Affairs: Sara Stradley
Lead Administrative Officer: Thomas Cunningham
Project Specialists: Velma Cunningham and Tasha Harris
 
Divisions

 

Mailing Address:

Food and Drug Administration
Center
for Drug Evaluation and Research
Office of Drug Evaluation II
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2310
Fax: (301) 796-9717